View in EDS HTML Full Text PDF Full Text

Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.

Saved in:
Bibliographic Details
Title: Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
Authors: Yang YY; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Deng RR; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China., Xiang DX; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 May 02; Vol. 18, pp. 1499-1514. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38716368
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+YY%22">Yang YY</searchLink>; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Deng+RR%22">Deng RR</searchLink>; School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Xiang+DX%22">Xiang DX</searchLink>; Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2024 May 02; Vol. 18, pp. 1499-1514. <i>Date of Electronic Publication: </i>2024 May 02 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38716368
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/DDDT.S443479
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1499
    Titles:
      – TitleFull: Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang YY
      – PersonEntity:
          Name:
            NameFull: Deng RR
      – PersonEntity:
          Name:
            NameFull: Xiang DX
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 05
              Text: 2024 May 02
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1177-8881
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: Drug design, development and therapy
              Type: main
ResultId 1